Prospective Preliminary Analysis of the Development of Autism and Epilepsy in Children With Infantile Spasms

Abstract

The objective of this study was to compare the efficacy of corticotropin (ACTH) versus vigabatrin in treating infantile spasms and to determine which medication has a more favorable long-term outcome in terms of cognitive function, evolution of epilepsy, and incidence of autism. Patients with infantile spasms were included in the study if they were 3 to 16 months old, had hypsarrhythmia, and had no previous treatment with vigabatrin or corticosteroids. Patient evaluation included electroencephalographic and psychometric measures before and after treatment. Patients were stratified based on etiology (idiopathic or symptomatic) and sex and then randomized between the ACTH and vigabatrin treatment groups. Each of the treatment groups received either ACTH or vigabatrin for 2 weeks. At the end of 2 weeks of treatment, patients were considered responders if spasms and hypsarrhythmia resolved. Nonresponders were crossed over and treated with the alternate drug. Nine patients were included in the study. Three patients received ACTH, one of whom was a responder. Six patients received vigabatrin, three of whom were responders. The five nonresponders received both therapies. All patients had some degree of developmental plateau or regression before the initiation of treatment. Four patients with idiopathic infantile spasms showed improved cognitive function following treatment. The remaining five patients remained significantly delayed. Five patients with symptomatic infantile spasms had epilepsy following treatment; three of them were in the autistic spectrum. The small number of infants in this pilot study is insufficient to determine which of the two drugs is more effective. However, the following trends were identified: vigabatrin may be more effective for patients with symptomatic infantile spasms; patients with idiopathic infantile spasms tend to have a better cognitive outcome; and patients with symptomatic infantile spasms tend to develop both epilepsy and autism. (J Child Neurol 2003; 18: 165—170).

Get full access to this article

View all access options for this article.

References

Riikonen R. : Long-term outcome of patients with West syndrome. Brain Dev 2001; 23: 683—687.

Baram TZ , Mitchell WG , Tournay A. , et al: High-dose corticotrophin (ACTH) versus prednisone for infantile spasms: A prospective, randomized, blinded study. Pediatrics 1996;97:375—379.

Snead OC , Benton JW , Myers GJ : ACTH and prednisone in childhood seizure disorders. Neurology 1983;33:966—970.

Trevathen E. , Murphy CC , Yeargin-Allsopp M. : The descriptive epidemiology of infantile spasms among Atlanta children. Epilepsia 1999;40:748—751.

Sidenvall R. , Eeg-Olofsson O. : Epidemiology of infantile spasms in Sweden. Epilepsia 1995;36:572—574.

Koo B. , Hwang P. , Logan W. , Hunjan A. : Infantile spasms: Outcome and prognosis factors of cryptogenic and symptomatic groups. Neurology 1993;43:2322—2327.

Rantala H. , Putkonen T. : Occurrence, outcome, and prognostic factors of infantile spasms and Lennox-Gastaut syndrome. Epilepsia 1999;40:286—289.

Lombroso C. : A prospective study of infantile spasms: Clinical and therapeutic correlations . Epilepsia 1983;24:135—158.

Riikonen R. , Amnell G. : Psychiatric disorders in children with earlier infantile spasms. Dev Med Child Neurol 1981; 23: 747—760.

10.

Hunt A. , Dennis J. : Psychiatric disorders among children with tuberous sclerosis. Dev Med Child Neurol 1987;29: 190—198.

11.

Sorel L. , Duscaucy-Bouloye A. : Appropos de cas d'hypsarythmie; de Gibbs: Son traitament spectaculaire par l'adrenocorticotropin hormone. Acta Neurol Belg 1958;58:130—141.

12.

Low NL : Infantile spasms with mental retardation: I. Treatment w i t h c o r t i s o n e a n d a d r e n o c o r t i c o t r o p h i n . P e d i a t r i c s 1958;22:1165—1169.

13.

Dumermuth G. : Uber die Blitz-Nick-Salaam Krampfe und ihre Behandlung mit adrenocorticotropin hormone und Hydrocortison. Mittleilung Helv Ped Acta 1959;14:250—270.

14.

Gastaut H. , Satfiel J. , Raybaud C. , et al: A propos du traitement par l'adrenocorticotropin hormone des encephalities myoclonic de la premiere enfance avec dysrythmie majeure (hypsarrythmie) . Pediatrie 1959;15:35—45.

15.

Stamps FW , Gibbs EL , Rosenthal IM , Gibbs FA : Treatment of hypsarrhythmia with ACTH. JAMA 1959;171:408—411.

16.

Livingston JH , Beaumont D. , Arzimanoglou A. , Aicardi J. : Vigabatrin in the treatment of epilepsy in children. Br J Clin Pharmacol 1989; 27(Suppl 1):109S—112S.

17.

Chiron C. , Dulac O. , Beaumont D. , et al: Therapeutic trial of vigabatrin in refractory infantile spasms . J Child Neurol 1991; 6 (Suppl 2):S52—S59.

18.

Vles JS , Van der Heyden AM , Ghijs A. , Troost J. : Vigabatrin in the treatment of infantile spasms. Neuropediatrics 1993;24:230—231.

19.

Aicardi J. , Mumford JP , Dumas C. , Wood S. : Vigabatrin as initial therapy for infantile spasms: A European retrospective study. Sabril IS, Investigator and Peer Review Groups. Epilepsia 1996; 37: 638—642.

20.

Kwong L. : Vigabatrin as first-line therapy in infantile spasms: Review of seven patients . J Pediatr Child Health 1997;33:121—124.

21.

Vigevano F. , Cilio MR : Vigabatrin versus adrenocorticotropin hormone as first-line treatment for infantile spasms: A randomized prospective study . Epilepsia 1997;38:1270—1274.

22.

Bayley N. : Bayley Scales of Infant Development, Second Edition. San Antonio, TX, The Psychological Corporation, 1993.

23.

Zimmerman IL , Steiner VG , Pond RE : Preschool Language Scale, 3rd ed. San Antonio, TX, Psychological Corporation, 1992. 24. Lord C. , Rutter M. , DiLavore PC : Autism Diagnostic Observation Schedule-Generic . Chicago, University of Chicago , 1997.

24.

Lord C. : Follow-up of two year olds referred for possible autism. J Child Psychol Psychiatry 1995 ;36:1365-1382.

25.

Hancock E. , Osborne JP , Milner P. : The treatment of West syndrome: A Cochrane Review of the literature to December 2000. Brain Dev 2001;23:624—634.

26.

Filipek PA , Accardo PJ , Ashwal S. , et al: Practice parameter: screening and diagnosis of autism: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Child Neurology Society. Neurology 2000; 55: 468—479.

27.

Stone WL , Lee EB , Ashford L. , et al: Can autism be diagnosed accurately in children under 3 years? J Child Psychol Psychiatry 1999;40:219—226.

28.

Zwaigenbaum L. , Bryson S. , Rombough V. , et al: Behavioural Risk Markers in 12-Month Old Siblings of Children With Autism. Presented at the International Conference for Infant Studies, Toronto , April, 2002.

29.

Brian JA , Bryson SE , Zwaigenbaum L. : Intervention Strategies for Infants Showing Very Early Signs of Autism. Poster session, Ontario Association for Behaviour Analysis Annual Conference, Toronto, November 2002.

30.

Osterling JA , Dawson G. , Munson JA : Early recognition of 1-year-old infants with autism spectrum disorder versus mental retardation. Dev Psychopathol 2002; 14: 239—251.

31.

Eke T. , Talbot JF , Lawden MC : Severe persistent visual field constriction associated with vigabatrin. BMJ 1997;314:180—181.

32.

Kramer G. , Scollo-Lavizzari G. , Jallon P. , et al: Vigabatrin-associated bilateral concentric visual field defects in four patients. Epilepsia 1997;38:179.

33.

Lawden MC , Eke T. , Degg C. , et al: Visual field defects associated with vigabatrin therapy. J Neurol Neurosurg Psychiatry 1999;67:716—722.

34.

Westall C. , Buncic R. , Logan W. , Panton C. : Longitudinal changes of ERGs in children on vigabatrin therapy, in Sharpe J (ed): Neuro-Ophthalmology in the New Millennium. Proceedings of the INOS Meeting , Toronto, Canada. Engelwood, NJ , Medimond Medical Publications, 2001, 29—34.

35.

Wohlrab G. , Boltshauser E. , Schmitt B. , et al: Visual field constriction is not limited to children treated with vigabatrin. Neuropediatrics 1999;30:130—132.

36.

Vanhatalo S. , Nousiainen I. , Eriksson K. , et al: Visual field constriction in 91 Finnish children treated with vigabatrin. Epilepsia 2002;43:748—756.